Frontlight ResearchEarly access
Bipolar disorder trials in Sweden
6 of 6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3WithdrawnA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Where
- Gothenburg, Nacka, Uppsala
- Age
- 18 years to 65 years
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951711 - Phase 3CompletedA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Where
- Stockholm
- Age
- 18 years to 65 years
- People
- 450 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00 - Phase 3Taking peoplePramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression
- Where
- Malmö
- Age
- 18 years to 80 years
- People
- 126
- Run by
- Daniel Lindqvist
See details and how to joinNCT07664852 · EU 2026-526383-20-00 - Phase 2Taking peopleOSU6162 in Bipolar Depression (OBID)
- Where
- Gothenburg
- Age
- 18 years to 65 years
- People
- 22
- Run by
- Göteborg University
See details and how to joinNCT05296356 · EU 2024-517560-30-00 - Phase 4Taking peopleRight-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression
- Where
- Örebro, Uppsala
- Age
- 18 years and over
- People
- 350
- Run by
- Region Örebro County
See details and how to joinNCT07026461 - Phase 4Taking peopleOptimal Electrical Stimulus During Electroconvulsive Therapy
- Where
- Örebro
- Age
- 18 years and over
- People
- 800
- Run by
- Region Örebro County
See details and how to joinNCT04057378